Focus Stocks
Trading Idea - Is Vmware close to Resistance?
Published on Thursday, 09 February 2012 05:40 Written by TradersHuddle Wire
New York, February 9th (TradersHuddle.com) - Shares of VMware, Inc. (NYSE:VMW) are trading very close to calculated resistance at $96.30 with the current price action closing at just $94.21 placing the stock near levels that make it difficult to buy.
VMware, Inc. (NYSE:VMW) provides virtualization solutions for the desktop computer and data centers. Its solution products addresses a range of IT problems, which includes cost and operational inefficiencies, business continuity, software lifecycle management and desktop management.
Vmware's current stock range is defined by current calculated support defined at $82.80 and by the resistance level at $96.30, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Vmware, as the stock is well above support, however, as the stock pulls back towards $82.80 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $96.30 then traders will get an opportunity to enter Vmware stock by establishing a position as the stock moves to a higher range.
Related Articles
- Critical Alerts For Monsanto, Newmont Mining, VMWare, Equinix, and Pier 1 Imports Released By InvestorsObserver
- EMC and VMware Extend Partnership to Develop, Sell and Deliver Storage Analytics for VNX
- Trading Idea: What to Expect with Vmware Breaking Support
- Vmware Is Near its 200 Day Moving Average
- Trading Idea: Is Vmware close to Support?
- Trading Idea: Is Vmware Breaking Down?
- Is Vmware Closing in to Support?
- Close to the 50 Day Moving Average: Vmware
- Vmware Is Near Resistance
Related Partner Headlines
- VMWare Inc. (VMW): Today's Featured Technology Loser - TheStreet.com
- VMware to Acquire Wanova - Benzinga
- VMWare Inc. (VMW): Today's Featured Computer Software & Services Loser - TheStreet.com
- VMWare Inc. (VMW): Today's Featured Computer Software & Services Loser - TheStreet.com
- VMware: The Disadvantage of Closed Source - TheStreet.com
- VMWare Inc. (VMW): Today's Featured Computer Software & Services Winner - TheStreet.com
- VMware: Value in the Cloud - TheStreet.com
- VMWare Stock Hits New 52-Week High (VMW) - TheStreet.com
- VMWare Reaches New 52-Week High (VMW) - TheStreet.com
- From Earlier: VMware Announces Authorization of Stock Repurchase Program of up to $600M - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









